Cambridge, UK, 28 January 2019 – Microbiotica, a leading player in microbiome-based therapeutics, is pleased to confirm upcoming conference activity for the first quarter of 2019.
Microbiome Drug Development Summit, 28-30 January 2019, Paris, France
The conference is designed to tackle the greatest scientific, regulatory, clinical, manufacturing and commercialisation challenges across the entire drug development value chain. Microbiotica is also a sponsor of this key event.
‘Precision Metagenomics Microbiome Analysis in Personalised Medicine’ – talk by Dr Trevor Lawley,
29 January, 11.30 – 11.50
‘New Perspectives on Pharma & Biotech Partnerships in the Microbiome’ – panel featuring Dr Mike Romanos,
29 January, 16.20 – 17.00
What’s New In Microbiome Research, 12 February 2019, Babraham Research Campus, UK
This event will provide a summary of the latest trends, research and industry thinking in the microbiome field, and will feature a presentation from Mike Romanos and other leading experts in the field.
‘Identifying gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers’ - presentation by Dr Mike Romanos, evening event 17.30 – 21.30